Teppei Morikawa

Summary

Affiliation: University of Tokyo
Country: Japan

Publications

  1. ncbi Tumor TP53 expression status, body mass index and prognosis in colorectal cancer
    Teppei Morikawa
    Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, and Department of Medicine Brigham and Women s Hospital, Boston, MA 02215, USA
    Int J Cancer 131:1169-78. 2012
  2. ncbi Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer
    Teppei Morikawa
    Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 19:1944-53. 2012
  3. ncbi Phyllodes tumor of the prostate with exuberant glandular hyperplasia
    Teppei Morikawa
    Department of Human Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
    Pathol Int 56:158-61. 2006
  4. ncbi Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer
    Teppei Morikawa
    Department of Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
    Histopathology 57:885-92. 2010
  5. ncbi Recurrent prostatic stromal sarcoma with massive high-grade prostatic intraepithelial neoplasia
    Teppei Morikawa
    Department of Human Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
    J Clin Pathol 60:330-2. 2007
  6. ncbi Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro
    Teppei Morikawa
    Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
    Hum Pathol 41:1742-8. 2010
  7. ncbi Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer
    Paul Lochhead
    Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, United States
    Eur J Cancer 48:3405-13. 2012
  8. ncbi TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers
    Kaori Shima
    Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America
    PLoS ONE 6:e25062. 2011
  9. ncbi Predictors of lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies
    Teppei Morikawa
    Department of Medical Oncology, Dana Farber Cancer Institute and Havard Medical School, Boston, MA 02215, USA
    Arch Surg 147:715-23. 2012
  10. ncbi Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review
    Xiaoyun Liao
    Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02215, USA
    Clin Cancer Res 18:2257-68. 2012

Collaborators

Detail Information

Publications34

  1. ncbi Tumor TP53 expression status, body mass index and prognosis in colorectal cancer
    Teppei Morikawa
    Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, and Department of Medicine Brigham and Women s Hospital, Boston, MA 02215, USA
    Int J Cancer 131:1169-78. 2012
    ..These molecular pathological epidemiology data may support a dual role of TP53 alterations in cell-cycle deregulation and cell autonomy with respect to energy balance status...
  2. ncbi Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer
    Teppei Morikawa
    Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 19:1944-53. 2012
    ..However, little is known about the prognostic significance of tumor growth pattern, independent of tumoral molecular alterations and other histologic features...
  3. ncbi Phyllodes tumor of the prostate with exuberant glandular hyperplasia
    Teppei Morikawa
    Department of Human Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
    Pathol Int 56:158-61. 2006
    ..The final diagnosis was then made as 'phyllodes tumor of the prostate with exuberant glandular hyperplasia'. Atypical stromal cells might provide a clue for the recognition of this rare tumor at initial diagnosis by needle biopsy...
  4. ncbi Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer
    Teppei Morikawa
    Department of Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
    Histopathology 57:885-92. 2010
    ..To examine the immunohistochemical expression and function of ribonucleotide reductase M2 subunit (RRM2), a gemcitabine-related molecule, in bladder cancer...
  5. ncbi Recurrent prostatic stromal sarcoma with massive high-grade prostatic intraepithelial neoplasia
    Teppei Morikawa
    Department of Human Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
    J Clin Pathol 60:330-2. 2007
    ..Our findings suggest that not only the stromal component but also and the epithelial components of PSS may have malignant potential...
  6. ncbi Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro
    Teppei Morikawa
    Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
    Hum Pathol 41:1742-8. 2010
    ..Our data suggest that ribonucleotide reductase M2 subunit overexpression could be associated with the gastric cancer progression and that suppression of its function is a potential therapeutic strategy in gastric cancer...
  7. ncbi Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer
    Paul Lochhead
    Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, United States
    Eur J Cancer 48:3405-13. 2012
    ..However, the clinical, pathological, molecular and prognostic features of IGF2BP3-positive colorectal cancers remain uncertain...
  8. ncbi TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers
    Kaori Shima
    Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America
    PLoS ONE 6:e25062. 2011
    ..However, a role of TGFBR2 or BAX mononucleotide mutation in colorectal cancer as a prognostic biomarker remains uncertain...
  9. ncbi Predictors of lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies
    Teppei Morikawa
    Department of Medical Oncology, Dana Farber Cancer Institute and Havard Medical School, Boston, MA 02215, USA
    Arch Surg 147:715-23. 2012
    ..To identify factors that influence the total and negative lymph node counts in colorectal cancer resection specimens independent of pathologists and surgeons...
  10. ncbi Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review
    Xiaoyun Liao
    Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02215, USA
    Clin Cancer Res 18:2257-68. 2012
    ..Thus, we hypothesized that PIK3CA exon 9 and exon 20 mutations might have differential effects on clinical outcome in colorectal cancer, and that concomitant PIK3CA exon 9 and 20 mutations might confer aggressive tumor behavior...
  11. ncbi Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers
    Yu Imamura
    Center for Molecular Oncologic Pathology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, 450 Brookline Ave, Room JF 215C, Boston, MA 02215, USA
    Clin Cancer Res 18:4753-63. 2012
    ..Cox proportional hazards model was used to compute mortality HR, adjusting for potential confounders, including stage, PIK3CA mutations, microsatellite instability, CpG island methylator phenotype, and LINE-1 methylation...
  12. ncbi Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level
    Shuji Ogino
    Center for Molecular Oncologic Pathology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, 450 Brookline Ave, Rm JF 215C, Boston, MA 02215, USA
    J Natl Cancer Inst 105:130-40. 2013
    ..We tested the hypothesis that CRC family history might confer a higher risk of LINE-1 methylation-low CRC...
  13. ncbi Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival
    Xiaoyun Liao
    Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA
    N Engl J Med 367:1596-606. 2012
    ....
  14. ncbi Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma
    Rumi Hino
    Department of Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo ku, Tokyo, Japan
    Cancer Res 69:2766-74. 2009
    ..LMP2A plays an essential role in the epigenetic abnormalities in host stomach cells and in the development and maintenance of EBV-associated cancer...
  15. ncbi Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer
    Teppei Morikawa
    Department of Medical Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215, USA
    JAMA 305:1685-94. 2011
    ..Alterations of the WNT signaling pathway and cadherin-associated protein β 1 (CTNNB1 or β-catenin) have been implicated in colorectal carcinogenesis and metabolic diseases...
  16. ncbi Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum
    Mai Yamauchi
    Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA
    Gut 61:847-54. 2012
    ..Considering a possible role of bowel contents (including microbiome) in carcinogenesis, this study hypothesised that tumour molecular features might gradually change along bowel subsites, rather than change abruptly at splenic flexure...
  17. ncbi STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers
    Teppei Morikawa
    Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Clin Cancer Res 17:1452-62. 2011
    ..Although the STAT3 signaling pathway is a potential drug target, clinical, pathologic, molecular, or prognostic features of STAT3-activated colorectal cancer remain uncertain...
  18. ncbi Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study
    Aya Kuchiba
    Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA
    J Natl Cancer Inst 104:415-20. 2012
    ..9 and 7.1, respectively, per 100,000 person-years. This molecular pathological epidemiology study supports a role of energy metabolism in colorectal cancer pathogenesis...
  19. ncbi Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status
    Teppei Morikawa
    Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215, USA
    Cancer Res 73:1600-10. 2013
    ..Furthermore, they suggest that energy balance and metabolism status exerts its effect in a specific carcinogenesis pathway that is less likely dependent on WNT/CTNNB1 activation...
  20. ncbi No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from H&E-stained archival tissue sections
    Teppei Morikawa
    Center for Molecular Oncologic Pathology, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Room JF 208E, Boston, MA 02215, USA
    Am J Clin Pathol 138:122-9. 2012
    ..Our data provide no evidence for an interfering effect of H&E staining on DNA testing, suggesting that DNA from H&E-stained sections can be effectively used for routine DNA testing...
  21. ncbi Phenotypic and tumor molecular characterization of colorectal cancer in relation to a susceptibility SMAD7 variant associated with survival
    Xabier Garcia-Albeniz
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    Carcinogenesis 34:292-8. 2013
    ..These findings suggest that individuals with this SMAD7 variant that develop CRC are more probably to have tumors with greater invasiveness and methylation of RUNX3, which potentially contributes to their poorer observed survival...
  22. ncbi MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers
    Kaori Shima
    Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    Cancer Causes Control 22:301-9. 2011
    ..MGMT promoter hypermethylation and epigenetic silencing often occur as early events in carcinogenesis. However, prognostic significance of MGMT alterations in colorectal cancer remains uncertain...
  23. ncbi Aberrations of a cell adhesion molecule CADM4 in renal clear cell carcinoma
    Masayoshi Nagata
    Division of Molecular Pathology, Institute of Medical Science, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
    Int J Cancer 130:1329-37. 2012
    ..Finally, introduction of CADM4 into an RCC cell line, 786-O, dramatically suppressed tumor formation in nude mice. These findings suggest that CADM4 is a novel tumor suppressor candidate in RCCC acting with its binding partner 4.1B...
  24. ncbi Subepithelial myofibroblast in lung adenocarcinoma: a histological indicator of excellent prognosis
    Daisuke Matsubara
    Department of Pathology, Jichi Medical University, Shimotsuke, Japan
    Mod Pathol 22:776-85. 2009
    ..A subset of invasive adenocarcinomas retains subepithelial myofibroblasts. Analysis of subepithelial myofibroblasts may be helpful in identifying a subset of lung adenocarcinoma with excellent prognosis...
  25. ncbi c-Met activation in lung adenocarcinoma tissues: an immunohistochemical analysis
    Yu Nakamura
    Department of Human Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
    Cancer Sci 98:1006-13. 2007
    ..c-Met activation may play special roles in the papillary subtype and in well differentiated lung adenocarcinomas...
  26. ncbi Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression
    Jennifer H Lin
    Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02215, USA
    Cancer Res 72:3020-8. 2012
    ..Together, our molecular pathological epidemiology findings suggest a preventive effect of hormone therapy against colorectal carcinogenesis that depends, in part, on loss of cyclin-dependent kinase inhibitor CDKN1A...
  27. ncbi Restriction of intestinal stem cell expansion and the regenerative response by YAP
    Evan R Barry
    Stem Cell Program and Department of Hematology Oncology, Children s Hospital, Boston, Massachusetts 02115, USA
    Nature 493:106-10. 2013
    ..Additionally, our findings have important implications for the targeting of YAP in human malignancies...
  28. ncbi Identification of chromosomal aberrations of metastatic potential in colorectal carcinoma
    Shogo Yamamoto
    Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, 4 6 1 Komaba, Tokyo, Japan
    Genes Chromosomes Cancer 49:487-96. 2010
    ..Consequently, CRC with and without liver metastasis harbor similar chromosomal aberrations, and chromosomal aberration at 6q, 20p, and 20q may be involved in the process of liver metastasis of CRC...
  29. ncbi Hypoxia increases the motility of lung adenocarcinoma cell line A549 via activation of the epidermal growth factor receptor pathway
    Tao Wang
    Department of Human Pathology, Graduate School of Medicine, The University of Tokyo, 7 3 1 Hongo, Bunkyo ku, 113 0033, Tokyo, Japan
    Cancer Sci 98:506-11. 2007
    ..Thus, the present study demonstrates the importance of the EGFR pathway in the increased motility of cancer cells that occurs in a hypoxic tumor environment...
  30. ncbi Oncofetal protein glypican-3 in testicular germ-cell tumor
    Satoshi Ota
    Department of Pathology, Graduate School of Medicine, University of Tokyo, Hongo 7 3 1, Bunkyo, Tokyo, 113 0033, Japan
    Virchows Arch 449:308-14. 2006
    ..Thus, GPC3 is a unique oncofetal protein, which is useful as an immunohistochemical marker for GCT differentiated to extraembryonic tissue, especially YST...
  31. ncbi Differential WNT activity in colorectal cancer confers limited tumorigenic potential and is regulated by MAPK signaling
    David Horst
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    Cancer Res 72:1547-56. 2012
    ..Furthermore, they suggest that MAPK signaling is a critical modifier of intratumoral heterogeneity that contributes significantly to determining the impact of WNT activity on stemness phenotypes in colon cancer cells...
  32. ncbi Metastatic seminomas in lymph nodes: CD10 immunoreactivity can be a pitfall of differential diagnosis
    Yasunori Ota
    Department of Pathology, Toranomon Hospital Tokyo, Japan
    Int J Clin Exp Pathol 6:498-502. 2013
    ..We further evaluated CD10 expression in a series of seminomas (n=16). Strong positivity was observed in 14 cases; partial and weak positivity, in 2 cases. These findings should be considered in the differential diagnosis of seminoma...
  33. ncbi Epstein-Barr virus-associated gastric carcinoma: a distinct carcinoma of gastric phenotype by claudin expression profiling
    Aya Shinozaki
    Department of Pathology, Graduate School of Medicine, The University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 0033, Japan
    J Histochem Cytochem 57:775-85. 2009
    ..EBV-associated GC may undergo distinct carcinogenic processes, which differ from those of EBV-negative GC...
  34. ncbi IgG4-related periureteral fibrosis presenting as a unilateral ureteral mass
    Hiroyuki Abe
    Department of Pathology, Asahi General Hospital, Chiba, Japan
    Pathol Res Pract 207:712-4. 2011
    ..It is important to consider IgG4-related sclerosing disease in the differential diagnosis of a unilateral ureteral mass...